ABL Bio-Technologies Ltd
ABL Bio Technologies Limited is an India-based company. The company is engaged in bio technology industry.
- Market Cap ₹ 0.66 Cr.
- Current Price ₹ 0.81
- High / Low ₹ /
- Stock P/E
- Book Value ₹ 21.8
- Dividend Yield 0.00 %
- ROCE -0.50 %
- ROE -0.97 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.04 times its book value
Cons
- Company has low interest coverage ratio.
- Company has a low return on equity of -31.8% over last 3 years.
- Contingent liabilities of Rs.4.52 Cr.
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | TTM | |
---|---|---|---|---|---|---|---|---|
7.00 | 9.27 | 16.86 | 8.15 | 2.22 | 0.04 | 0.00 | 0.00 | |
5.76 | 7.54 | 13.63 | 7.76 | 22.22 | 0.57 | 0.12 | 0.02 | |
Operating Profit | 1.24 | 1.73 | 3.23 | 0.39 | -20.00 | -0.53 | -0.12 | -0.02 |
OPM % | 17.71% | 18.66% | 19.16% | 4.79% | -900.90% | -1,325.00% | ||
1.01 | 1.56 | 0.10 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | |
Interest | 0.28 | 0.62 | 1.16 | 1.12 | 0.52 | 0.00 | 0.00 | 0.00 |
Depreciation | 0.16 | 0.21 | 0.22 | 0.23 | 0.12 | 0.07 | 0.07 | 0.11 |
Profit before tax | 1.81 | 2.46 | 1.95 | -0.96 | -20.64 | -0.60 | -0.18 | -0.13 |
Tax % | 7.18% | 12.60% | 9.74% | 1.04% | 0.00% | 0.00% | 0.00% | |
1.68 | 2.15 | 1.76 | -0.97 | -20.64 | -0.60 | -0.18 | -0.12 | |
EPS in Rs | -1.18 | -25.17 | -0.73 | -0.22 | -0.16 | |||
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -100% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 22% |
TTM: | 20% |
Stock Price CAGR | |
---|---|
10 Years: | -14% |
5 Years: | % |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | -19% |
3 Years: | -32% |
Last Year: | -1% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | |
---|---|---|---|---|---|---|---|
Equity Capital | 4.10 | 4.10 | 4.10 | 8.20 | 8.20 | 8.20 | 8.20 |
Reserves | 0.94 | 6.76 | 8.52 | 32.01 | 11.13 | 10.54 | 10.36 |
5.17 | 10.13 | 14.14 | 16.59 | 16.66 | 16.96 | 17.10 | |
4.33 | 6.40 | 7.84 | 8.88 | 9.60 | 9.53 | 9.43 | |
Total Liabilities | 14.54 | 27.39 | 34.60 | 65.68 | 45.59 | 45.23 | 45.09 |
2.67 | 7.38 | 7.59 | 7.42 | 35.10 | 34.86 | 34.79 | |
CWIP | 0.00 | 5.92 | 7.34 | 7.62 | 0.00 | 0.00 | 0.00 |
Investments | 1.30 | 1.30 | 1.30 | 1.30 | 1.30 | 1.30 | 1.31 |
10.57 | 12.79 | 18.37 | 49.34 | 9.19 | 9.07 | 8.99 | |
Total Assets | 14.54 | 27.39 | 34.60 | 65.68 | 45.59 | 45.23 | 45.09 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | |
---|---|---|---|---|---|---|---|
-3.33 | 1.79 | -1.64 | 0.77 | -9.56 | -0.47 | -0.11 | |
-0.05 | -5.28 | -1.90 | -0.89 | -19.88 | 0.17 | -0.02 | |
3.38 | 5.99 | 1.21 | 29.97 | -0.45 | 0.36 | 0.13 | |
Net Cash Flow | 0.00 | 2.50 | -2.33 | 29.85 | -29.89 | 0.06 | 0.00 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | |
---|---|---|---|---|---|---|---|
Debtor Days | 159.56 | 120.88 | 163.45 | 320.66 | 44.39 | 2,920.00 | |
Inventory Days | 187.68 | 198.51 | 113.16 | 252.04 | 6.53 | 0.00 | |
Days Payable | 477.84 | 353.79 | 277.75 | 706.40 | 827.08 | ||
Cash Conversion Cycle | -130.60 | -34.41 | -1.14 | -133.69 | -776.16 | 2,920.00 | |
Working Capital Days | 255.50 | 141.75 | 214.54 | 424.12 | -159.48 | -8,942.50 | |
ROCE % | 19.81% | 13.24% | 0.41% | -43.37% | -1.67% | -0.50% |
Documents
Announcements
- Standalone Financial Results, Limited Review Report for September 30, 2016 14 Nov 2016
- Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016 22 Oct 2016
- Limited Review Report for June 30, 2016 21 Oct 2016
- Board Meeting Intimation for Results 21 Oct 2016
- Outcome of AGM 30 Sep 2016